Cite
HARVARD Citation
Saif, M. et al. (2019). Open‐label study to evaluate trifluridine/tipiracil safety, tolerability and pharmacokinetics in patients with advanced solid tumours and hepatic impairment. British journal of clinical pharmacology. 85 (6), pp. 1239-1246. [Online].